Medunik USA Inc.
$2.1K 52 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Thermo Fisher Scientific Asheville LLC
Thermo Fisher Scientific Asheville LLC reported $2,190.64 across General Payments, Research, and Ownership to 13 physicians and teaching hospitals across 13 transactions.
- $2.2K
- All-tracks total
- 13
- Transactions
- 13
- Recipients
- −$2.1K
- General Payments vs PY2023
Thermo Fisher Scientific Asheville LLC reported $2,190.64 across all CMS Open Payments tracks (General + Research + Ownership) to 13 physicians and teaching hospitals in Program Year 2024 - ranking #1789 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,190.64, averaging $168.51 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer thermo-fisher-scientific-asheville-llc Thermo Fisher Scientific Asheville LLC
$2.2K · #1789/1,925 · 0.0% industry · PY2024
- TOT $2.2K
- RANK #1789
- SHARE 0.0%
- TXN 13
- RCP 13
- CAT 1
- GEN $2.2K
- ΔGEN −$2.1K
- TOP1 33.2%
- PY 2024
Volume peers
Nearest volume peer: Medunik USA Inc. ($2.1K)
Thermo Fisher Scientific Asheville LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Thermo Fisher Scientific Asheville LLC's CMS-reported General Payments decreased by $2.1K (−49.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: THERMO FISHER SCIENTIFIC ASHEVILLE LLCPY2024: Thermo Fisher Scientific Asheville LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,298.70
- PY2024
- $2,190.64
What the Data Shows for Thermo Fisher Scientific Asheville LLC
Averaging $168.51 per transaction and $168.51 per recipient, Thermo Fisher Scientific Asheville LLC's Program Year 2024 total comes to $2,190.64 across 13 transactions and 13 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1789 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Debt Forgiveness" at $2.2K, accounting for 100.0% of this company's General Payments and 13 transactions.
General Payment Breakdown by Type
Across 1 types of general payments, Thermo Fisher Scientific Asheville LLC's largest category was "Debt Forgiveness" at $2.2K - 100.0% of General Payments.
How Thermo Fisher Scientific Asheville LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Debt Forgiveness | $2.2K | 13 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,636.03 (74.7%) of $2,190.64 in this company's General Payments records across 11 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Thermo Fisher Scientific Asheville LLC
The five named recipients with the highest reported General Payments from this company
- 1
Valley Medical Center
$726.66 across 1 reported transactions
- 2
St. Josephs Hospital & Medical Ctr
$388.80 across 1 reported transactions
- 3
Spectrum Health Hospitals
$215.28 across 2 reported transactions
- 4
University Of Vermont Medical Center
$164.00 across 1 reported transactions
- 5
Anne Arundel Medical Center Inc.
$141.29 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Thermo Fisher Scientific Asheville LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Thermo Fisher Scientific Asheville LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Thermo Fisher Scientific Asheville LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Dymicron
$2.3K 1 recipients
Compare payment profiles
Vision Quest Industries Inc.
$2.1K 72 recipients
Compare payment profiles
American National Red Cross
$2.1K 11 recipients
Compare payment profiles
Elekta Medical, S.A.
$2.3K 1 recipients
Compare payment profiles
Oxford Gene Technology Inc
$2.3K 87 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.